Logo image
Oral oestrogen reverses ovariectomy-induced morning surge hypertension in growth-restricted mice
Journal article   Peer reviewed

Oral oestrogen reverses ovariectomy-induced morning surge hypertension in growth-restricted mice

Sarah E Haskell, Veronica Peotta, Benjamin E Reinking, Catherine Zhang, Vivian Zhu, Elizabeth J Kenkel and Robert D Roghair
Clinical science (1979), Vol.130(8), pp.613-623
04/2016
DOI: 10.1042/CS20150693
PMCID: PMC5036530
PMID: 26795436
url
http://doi.org/10.1042/CS20150693View
Open Access

Abstract

Perinatal growth restriction (GR) is associated with heightened sympathetic tone and hypertension. We have previously shown that naturally occurring neonatal GR programmes hypertension in male but not female mice. We therefore hypothesized that intact ovarian function or post-ovariectomy (OVX) oestrogen administration protects GR female mice from hypertension. Utilizing a non-interventional model that categorizes mice with weanling weights below the tenth percentile as GR, control and GR adult mice were studied at three distinct time points: baseline, post-OVX and post-OVX with oral oestrogen replacement. OVX elicited hypertension in GR mice that was significantly exacerbated by psychomotor arousal (systolic blood pressure at light to dark transition: control 122 ± 2; GR 119 ± 2; control-OVX 116 ± 3; GR-OVX 126 ± 3 mmHg). Oestrogen partially normalized the rising blood pressure surge seen in GR-OVX mice (23 ± 7% reduction). GR mice had left ventricular hypertrophy, and GR-OVX mice in particular had exaggerated bradycardic responses to sympathetic blockade. For GR mice, a baseline increase in baroreceptor reflex sensitivity and high frequency spectral power support a vagal compensatory mechanism, and that compensation was lost following OVX. For GR mice, the OVX-induced parasympathetic withdrawal was partially restored by oestrogen (40 ± 25% increase in high frequency spectral power, P<0.05). In conclusion, GR alters cardiac morphology and cardiovascular regulation. The haemodynamic consequences of GR are attenuated in ovarian-sufficient or oestrogen-replete females. Further investigations are needed to define the role of hormone replacement therapy targeted towards young women with oestrogen deficiency and additional cardiovascular risk factors, including perinatal GR, cardiac hypertrophy and morning surge hypertension.
Adaptation, Physiological Estrogen Replacement Therapy Heart Rate Body Weight Ovariectomy Administration, Oral Mice, Inbred C57BL Estradiol - administration & dosage Cardiovascular System - innervation Cardiovascular System - drug effects Nicotinic Antagonists - pharmacology Ganglionic Blockers - pharmacology Circadian Rhythm Motor Activity Hypertension - physiopathology Hypertension - etiology Baroreflex - drug effects Animals Time Factors Adrenergic alpha-1 Receptor Antagonists - pharmacology Hypertension - prevention & control Female Blood Pressure - drug effects Disease Models, Animal

Details

Metrics

Logo image